Chugai Pharmaceutical Co., Ltd.
Chugai Pharmaceutical Co., Ltd. is a Private limited company (Ltd.) registered in Japan under 5011501002900, and its current status with National Tax Agency — Corporate Number Publication Site is active. The company was incorporated on 5 October 2015 and lists its registered address as Kita Ward, Japan. 3 shareholders are on record for Chugai Pharmaceutical Co., Ltd., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from National Tax Agency — Corporate Number Publication Site and was last updated on 1 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
3
Shareholders of Chugai Pharmaceutical Co., Ltd.
Three shareholders are currently on record for Chugai Pharmaceutical Co., Ltd., reflecting the kabunushi meibo (shareholder register) maintained under Articles 121-122 of the Companies Act rather than a public filing. The largest of these is iShares Trust-iShares Core MSCI EAFE ETF, holding 8.8% — the largest recorded stake — followed by EuroPacific Growth Fund-EUPAC Fund at 7.6%; the remaining 1 shareholder shown holds smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Data-provider feed — rows as supplied to Zavia for National Tax Agency — Corporate Number Publication Site, including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| iShares Trust-iShares Core MSCI EAFE ETF | 8.8% | National Tax Agency — Corporate Number Publication Site | |
| EuroPacific Growth Fund-EUPAC Fund | 7.6% | National Tax Agency — Corporate Number Publication Site | |
| T. ROWE PRICE Intl Fd.S, INC.-T. Rowe Price Overseas Stock Fd. | 7.2% | National Tax Agency — Corporate Number Publication Site |
Officers
5
Directors and officers of Chugai Pharmaceutical Co., Ltd.
The Head Of Marketing & Sales Division of Chugai Pharmaceutical Co., Ltd. currently on record is Junichi Takano; five officers are currently on record for Chugai Pharmaceutical Co., Ltd., filed with National Tax Agency — Corporate Number Publication Site. Management authority at Chugai Pharmaceutical Co., Ltd. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Data availability
The register reports 14 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Data-provider feed — rows as supplied to Zavia for National Tax Agency — Corporate Number Publication Site, including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.
Group Structure
Group structure of Chugai Pharmaceutical Co., Ltd.
Chugai Pharmaceutical Co., Ltd. sits 2 levels below its ultimate parent, Artuma Holding GmbH, registered in Switzerland. 10 subsidiaries are recorded beneath it, across 7 jurisdictions. The full chain up to Artuma Holding GmbH is derived by walking shareholder filings across jurisdictions; no link in it is independently corroborated by Chugai Pharmaceutical Co., Ltd.'s own shareholder record. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
- Chugai Pharma China Co., Ltd. (China)
- CHUGAI CLINICAL RESEARCH CENTER CO., LTD. (Japan)
- CHUGAI BUSINESS SOLUTION CO., LTD. (Japan)
- CHUGAI PHARMA MANUFACTURING CO., LTD. (Japan)
- CHUGAI PHARMA FRANCE (France)
- CHUGAI PHARMA EUROPE LIMITED (United Kingdom)
- CHUGAI RESEARCH INSTITUTE FOR MEDICAL SCIENCE, INC. (Japan)
- Chugai Pharma Taiwan Ltd. (Taiwan)
- CHUGAI PHARMABODY RESEARCH PTE. LTD. (Singapore)
- Chugai Pharma Usa, Inc. (United States)
Data availability
Those 10 subsidiaries span Japan, China, France, United Kingdom, Taiwan, Singapore, and 1 more jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. Two of the 10 go a level deeper still, with their own further subsidiaries recorded beneath them — additional ownership layers this view doesn't expand.
Data-provider feed — rows as supplied to Zavia for National Tax Agency — Corporate Number Publication Site, including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.
Artuma Holding GmbH
Switzerland
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Chugai Pharmaceutical Co., Ltd.?
Three shareholders are currently on record for Chugai Pharmaceutical Co., Ltd., reflecting the kabunushi meibo (shareholder register) maintained under Articles 121-122 of the Companies Act rather than a public filing. The largest of these is iShares Trust-iShares Core MSCI EAFE ETF, holding 8.8% — the largest recorded stake — followed by EuroPacific Growth Fund-EUPAC Fund at 7.6%; the remaining 1 shareholder shown holds smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Chugai Pharmaceutical Co., Ltd.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Chugai Pharmaceutical Co., Ltd. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Chugai Pharmaceutical Co., Ltd. have on record?
3 shareholders are shown on record for Chugai Pharmaceutical Co., Ltd..
What is Chugai Pharmaceutical Co., Ltd.'s company registration number?
Chugai Pharmaceutical Co., Ltd.'s registration number is 5011501002900, filed with National Tax Agency — Corporate Number Publication Site in Japan. Its current status on the register is active.
Is Chugai Pharmaceutical Co., Ltd. still an active company?
Chugai Pharmaceutical Co., Ltd.'s status on National Tax Agency — Corporate Number Publication Site is listed as active.
When was Chugai Pharmaceutical Co., Ltd. incorporated?
Chugai Pharmaceutical Co., Ltd. was incorporated on 5 October 2015, according to National Tax Agency — Corporate Number Publication Site.
What is Chugai Pharmaceutical Co., Ltd.'s registered address?
The registered address on file for Chugai Pharmaceutical Co., Ltd. is Kita Ward, Japan.
What legal structure is Chugai Pharmaceutical Co., Ltd. registered as?
Chugai Pharmaceutical Co., Ltd. is registered as a Private limited company (Ltd.) in Japan.
Who are the officers/directors of Chugai Pharmaceutical Co., Ltd.?
The Head Of Marketing & Sales Division of Chugai Pharmaceutical Co., Ltd. currently on record is Junichi Takano; five officers are currently on record for Chugai Pharmaceutical Co., Ltd., filed with National Tax Agency — Corporate Number Publication Site. Management authority at Chugai Pharmaceutical Co., Ltd. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does Chugai Pharmaceutical Co., Ltd. have a parent company or subsidiaries?
Chugai Pharmaceutical Co., Ltd. sits 2 levels below its ultimate parent, Artuma Holding GmbH, registered in Switzerland. 10 subsidiaries are recorded beneath it, across 7 jurisdictions. Those 10 subsidiaries span Japan, China, France, United Kingdom, Taiwan, Singapore, and 1 more jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. Two of the 10 go a level deeper still, with their own further subsidiaries recorded beneath them — additional ownership layers this view doesn't expand.
Can Zavia monitor changes to Chugai Pharmaceutical Co., Ltd.'s ownership over time?
This profile reflects a point-in-time snapshot from National Tax Agency — Corporate Number Publication Site. Zavia's monitoring API can track changes to Chugai Pharmaceutical Co., Ltd.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Chugai Pharmaceutical Co., Ltd.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Japan, so records like Chugai Pharmaceutical Co., Ltd.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from National Tax Agency — Corporate Number Publication Site and was last synced on 1 October 2026.